Yan Peng

Title: Innovations of Yan Peng in Drug Crystallization

Introduction

Yan Peng is an accomplished inventor based in Lianyungang, China. He has made significant contributions to the field of drug crystallization, particularly with his innovative work on DPP-IV inhibitors. His research focuses on enhancing the stability and flowability of drug crystals, which is crucial for pharmaceutical applications.

Latest Patents

Yan Peng holds a patent for "Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof." This invention pertains to the field of drug crystals and specifically addresses the A and B type crystals of a compound represented in formula 7. The crystals developed by Yan Peng exhibit excellent stability, maintaining their material contents under high temperature, high humidity, or light exposure. Additionally, these crystals demonstrate superior powder flowability, meeting the stringent requirements for drug preparation and production.

Career Highlights

Throughout his career, Yan Peng has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.

Collaborations

Yan Peng has collaborated with several professionals in his field, including Fei Liu and Zhilin Chen. These collaborations have fostered a productive environment for research and innovation, leading to significant advancements in drug crystallization techniques.

Conclusion

Yan Peng's contributions to the field of drug crystallization, particularly through his patented work on DPP-IV inhibitors, highlight his role as a key innovator in the pharmaceutical industry. His focus on stability and flowability in drug crystals is paving the way for improved drug formulations.